Navigation Links
Cellular Biomedicine Group Announces New Product Approved for Market in China and New Exclusive License
Date:10/30/2013

PALO ALTO, Calif., Oct. 30, 2013 /PRNewswire/ -- Today Cellular Biomedicine Group (OTCQB:CBMG) announced that their A-Stromal™ adipose stromal cell purification kit is ready to launch on the market in China. In addition, they have signed an exclusive China and Hong Long license for ProCeller computer controlled processing system to extract stem cells from adipose tissue. These two products, when used together, allow for safe and contaminant-free isolation of one million Vascular Stromal Cells per 1 mL of adipose tissue in as little as sixty minutes. The potential clients for both products are cosmetic clinics, research institutions, sports medicine departments and veterinarian clinics.

About A-Stromal™
The A-Stromal™ kit was developed completely in-house by Cellular Biomedicine Group, Inc. and is covered by two China patents. The China Food and Drug Administration (CFDA) approved this kit as a medical device and it is the first certified product of its kind in China. It contains all critical reagents and material to purify Vascular Stromal Cells (VSC) or Stromal Vascular Fraction (SVF) from adipose (fat) tissue and includes detailed instructions for use and hands-on training.

Dr. William Cao, CEO of Cellular Biomedicine Group, Inc., explained, "The proprietary protocols of the A-Stromal™ kit provide a high concentration of VSC, averaging one million VSC cells per 1 mL of adipose tissue, with greater than 90% cell viability. This allows the doctor to extract a very small amount of adipose tissue from the patient in order to isolate enough VSC required for a therapeutic or cosmetic procedure."

The A-Stromal™ kits will be manufactured in Cellular Biomedicine Group's cGMP-certified facility in Wuxi, China
'/>"/>

SOURCE Cellular Biomedicine Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Cellular Biomedicine Group Reports Second Quarter and First Half 2013 Financial Results and Business Highlights
2. Decellularized mouse heart beats again after regenerating with human heart precursor cells
3. Cellular Dynamics International Announces Launch of Initial Public Offering
4. Cellular Biomedicine Group Announces Expansion in the Osteoarthritis and Rheumatoid Arthritis Market
5. Cellular Therapy and Cord Blood 2013 Market Report
6. Cellular Biomedicine Group Announces Appointment of Corporate Controller
7. Cellular Dynamics International Expands MyCell Products Line with Disease Models, Genetic Engineering Patents
8. Cellular Dynamics International Files Registration Statement for Proposed Initial Public Offering
9. Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis
10. Intra-Cellular Therapies Appoints Professor Sir Michael Rawlins to its Board of Directors
11. Top Genetic and Cellular Researchers Honored at ASGCT 16th Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... severe flooding that devastated a wide swath of Colorado ... bridges, roads and other infrastructure had been upgraded or ... of Colorado Denver. , "People need to understand the ... associate professor of structural engineering at the CU Denver ... the study. "There is an assumption that a bridge ...
(Date:10/27/2014)... Mass. and TORONTO ... Corporation ( www.generex.com ) (OTCQB: GNBT) today announced ... immunological response triggered by its novel proprietary cancer ... relapse in breast cancer patients. The AE37 cancer ... subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ). The ...
(Date:10/27/2014)... Called the NOAH Protocol, this investigative ... of pediatric brain cancer. The implications for groundbreaking ... years of research and development. Amber Larkin, the ... mom's determination can make a difference. , ... it’s only fitting that we’ve received FDA approval ...
(Date:10/27/2014)... -- Investor-Edge has initiated coverage on the ... ), Insmed Inc. (NASDAQ: INSM ), BioCryst ... (NASDAQ: DYAX ), and Oncothyreon Inc. (NASDAQ: ... accessed at: http://investor-edge.com/register . On Friday, ... up 0.69%, the Dow Jones Industrial Average advanced 0.76%, ...
Breaking Biology Technology:CU Denver study says upgrading infrastructure could reduce flood damage 2Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 2Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 3Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 4FDA Approves Breakthrough in Pediatric Brain Cancer - First in 30 Years 2FDA Approves Breakthrough in Pediatric Brain Cancer - First in 30 Years 3Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 2Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 3Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 4Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 5
... invention from Tel Aviv University a network of tiny ... foil even the most determined intruder. Scattered outdoors on ... of a bank, the dewdrops are a completely new and ... , Prof. Yoram Shapira and his Tel Aviv University Faculty ...
... (R) (lacosamide) C-V, a new antiepileptic drug (AED), ... week of June 2009. Vimpat was approved by ... the use as an add-on therapy for the treatment ... with epilepsy.(Photo: http://www.newscom.com/cgi-bin/prnh/20090526/NY22555 )Vimpat approval is ...
... old man with inoperable lung cancer is able to ... Surgeons told Donald Bickford, 71, that due to ... not an option for removing his lung tumor. To ... Wentworth-Douglass Hospital here, prescribed a type of non-invasive radiosurgery ...
Cached Biology Technology:Intruder alert: Tel Aviv University's 'Smart Dew' will find you! 2Vimpat(R) (lacosamide) C-V, a New Antiepileptic Drug (AED), To Be Available in U.S. Pharmacies 2Vimpat(R) (lacosamide) C-V, a New Antiepileptic Drug (AED), To Be Available in U.S. Pharmacies 3Doctors in New Hampshire Now Treating Cancer with Non-Invasive Image-Guided Radiosurgery Using Novalis Tx(TM) Technology 2Doctors in New Hampshire Now Treating Cancer with Non-Invasive Image-Guided Radiosurgery Using Novalis Tx(TM) Technology 3
(Date:10/29/2014)... but they also need protection from its harmful rays, just ... in plants that shields them from sun damage. Now, in ... Society , one team reports on the mechanics of how ... at Purdue University note that the harsh ultraviolet radiation plants ... DNA and, as a result, hinder plant growth. Biochemical ...
(Date:10/29/2014)... German . ... Schlögelhofer at the Max F. Perutz Laboratories (MFPL) of ... Vienna dived into the process of meiosis in specific ... inversion of the standard meiotic phases. The researchers describe ... Communications . , Meiosis is the two-step series of ...
(Date:10/29/2014)... October 29, 2014 – Ghrelin is a hormone released ... intake. Alcohol is commonly viewed as a psychoactive substance ... a highly caloric food. , This knowledge, combined ... hypothesis that ghrelin has the potential to stimulate alcohol ... this in humans and found that, as they had ...
Breaking Biology News(10 mins):Meiotic cell division 'the other way round' 2Ghrelin stimulates an appetite for drinking alcohol 2
... analysis indicates that birds don,t fly alone when migrating at ... journeys, flying in tandem even when they are 200 meters ... University of Illinois and the Illinois Natural History Survey, appears ... is the first to confirm with statistical data what many ...
... numbers of cycles of preimplantation genetic diagnosis or screening ... in 2004 (the most recent year for which data ... a growing number of genetically related conditions, but what ... condition are available for transfer and the parents request ...
... the journal Plant Physiology provides a comprehensive ... the rapidly growing Rosaceae scientific community. ... that comprises more than 3,000 species, including strawberry, apple, ... high-value nutritional foods and they are also the source ...
Cached Biology News:Birds migrate together at night in dispersed flocks, new study indicates 2Birds migrate together at night in dispersed flocks, new study indicates 3Should embryos with a hereditary disorder be transferred if no unaffected embryos are available? 2Should embryos with a hereditary disorder be transferred if no unaffected embryos are available? 3Review article provides tools for the Rosaceae genomics community 2